Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-13

Clinical Trial Update: Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating vitamin D to enhance immune function in cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Emory University | Conditions: Cystic Fibrosis, Respiratory Tract Infections | Phase 3 | Status: COMPLETED